Lubrizol’s MAGSHAPE™ Microcapsules Proven to Enhance Magnesium Absorption in New Clinical Study
Lubrizol’s MAGSHAPE™ microcapsules, a micronized and microencapsulated source of magnesium, have been found to significantly enhance magnesium absorption compared to other commonly used magnesium sources, according to a study published in Nutrients. Conducted by researchers at Bionos Biotech SL and Lubrizol Nutraceuticals, the study highlights the superior bioavailability and reduced side effects of this innovative solution, making it an ideal choice for those seeking science-backed magnesium products.
Superior Bioavailability and Reduced Side Effects
The clinical study, a double-blind, randomized, cross-over trial involving 40 healthy volunteers, aimed to evaluate the effectiveness of MAGSHAPE™ microcapsules in enhancing magnesium absorption. Participants were administered different magnesium supplements, including magnesium oxide, magnesium citrate, and magnesium bisglycinate, under controlled conditions. Blood samples were collected at zero (baseline), one, four, and six hours post-intake to measure blood plasma magnesium (Mg) levels. A secondary goal was to assess the prevalence of side effects often associated with magnesium supplementation, such as gastrointestinal discomfort.
The study revealed that MAGSHAPE™ microcapsules increased blood plasma Mg levels at all tested time points after the baseline reading. Importantly, the microencapsulation technology enabled a sustained increase in blood plasma Mg levels, maintaining higher levels for up to six hours post-intake. Participants also reported fewer adverse effects, such as intestinal motility and gastric heaviness, compared to other magnesium sources.
Consumer Preference and Scientific Validation
Prior to this clinical study, a consumer study conducted by Lubrizol Nutraceuticals found that participants preferred the taste and texture of MAGSHAPE™ microcapsules over magnesium from four other common sources. This consumer preference, combined with the scientific validation from the recent clinical study, underscores the potential of MAGSHAPE™ to revolutionize magnesium supplementation.
Innovative Technology Behind MAGSHAPE™
Isabel Gomez, Marketing Manager of Lubrizol Nutraceuticals, emphasized the significance of these findings: “These results demonstrate the potential of MAGSHAPE™ microcapsules to transform magnesium supplementation. The study compared MAGSHAPE microencapsulated magnesium oxide to magnesium oxide as a raw active ingredient and showed that the enhanced absorption and reduced side effects can be attributed to the innovative technologies employed to produce the MAGSHAPE™ microcapsules.”
Alan Connolly, R&D Manager of Lubrizol Nutraceuticals, added, “Based on the observed increase in blood plasma magnesium levels, this innovative solution has the potential to benefit individuals seeking to maintain adequate magnesium levels for overall health and well-being, as well as those looking to improve muscle recovery or enhance sleep patterns.”
Gastric Tolerability and Sustained Absorption
Teresa Negra, New Business Development Specialist at Lubrizol Nutraceuticals, highlighted the importance of gastric tolerability: “The reported gastric tolerability of MAGSHAPE™ by study participants, coupled with the statistically significant increase and sustained absorption profile, makes it a good option for those seeking the health benefits associated with maintaining adequate magnesium levels.”
Applications and Benefits
Magnesium plays a crucial role in various bodily functions, including muscle function, nerve transmission, and bone health. Adequate magnesium levels are essential for maintaining overall health and well-being. MAGSHAPE™ microcapsules offer a convenient and effective way to ensure sufficient magnesium intake, with minimal side effects and enhanced bioavailability. This makes it an ideal solution for individuals looking to support muscle recovery, enhance sleep quality, and promote general health.
Learn More About MAGSHAPE™
To learn more about MAGSHA™, request a sample, or obtain additional information, visit Contact – Lubrizol.
About The Lubrizol Corporation
The Lubrizol Corporation, a subsidiary of Berkshire Hathaway, is a science-based company dedicated to delivering sustainable solutions that advance mobility, improve well-being, and enhance modern life. With a history dating back to 1928, Lubrizol has established a global presence with over 100 manufacturing facilities, sales and technical offices, and nearly 8,000 employees worldwide. Lubrizol’s innovators strive to create extraordinary value for customers by bridging science, market needs, and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better.
For more information, visit www.Lubrizol.com.
By leveraging cutting-edge technology and rigorous scientific research, Lubrizol continues to innovate and deliver high-quality solutions that meet the evolving needs of consumers and industries alike. MAGSHAPE™ is just one example of how Lubrizol is transforming the supplement industry and improving lives through sustainable, science-backed products.
